Figure 7.
Figure 7. T-cell subset analyses in hu-PBL-NOD/SCID mice after NP-IDV-BMM treatment. (A) Flow cytometric histograms of splenocytes from mice 14 days following NP-IDV-BMM treatments were used to determine the numbers of mouse CD45 cells and human reconstituted CD4+ and CD8+ T cells. (B) The level of human lymphocyte reconstitution in mouse spleens was determined compared with mouse CD45+ cells. (C-D) Frequencies of (C) CD4+ and (D) CD8+ T cells were assessed as percentages of total human T cells. (E) Ratios of CD4+/CD8+ T cells increased significantly in NP-IDV-BMM-treated group compared with control animals. Data represent mean ± SEM for 4-6 mice/group. *P < .05 and **P < .01 compared with untreated controls.

T-cell subset analyses in hu-PBL-NOD/SCID mice after NP-IDV-BMM treatment. (A) Flow cytometric histograms of splenocytes from mice 14 days following NP-IDV-BMM treatments were used to determine the numbers of mouse CD45 cells and human reconstituted CD4+ and CD8+ T cells. (B) The level of human lymphocyte reconstitution in mouse spleens was determined compared with mouse CD45+ cells. (C-D) Frequencies of (C) CD4+ and (D) CD8+ T cells were assessed as percentages of total human T cells. (E) Ratios of CD4+/CD8+ T cells increased significantly in NP-IDV-BMM-treated group compared with control animals. Data represent mean ± SEM for 4-6 mice/group. *P < .05 and **P < .01 compared with untreated controls.

Close Modal

or Create an Account

Close Modal
Close Modal